HomeLatest NewsFederal NewsCMS proposes rule to require manufacturers to disclose drug prices

CMS proposes rule to require manufacturers to disclose drug prices

The Centers for Medicare & Medicaid Services (CMS) has proposed a rule (CMS-4187) that will require prescription drug manufacturers to disclose in television ads the wholesale acquisition cost for Medicare or Medicaid prescription drugs.

The proposed rule is the latest in President Trump’s efforts to lower prescription drug prices and increase price transparency. Under the proposed rule, the price required to be posted would be for a typical course of treatment for an acute medication like an antibiotic, or a 30-day supply of medication for a chronic condition that is taken every month. The posting would take the form of a legible statement at the end of the ad. Prescription drugs with a list price of less than $35 per month would be exempt.

Read the policy brief on CMS-4187 and the proposed rule. Comments will be accepted until Dec. 17 and can be submitted here.

Stay Connected

Unified Voice Newsletter

Events This Month


04apr9:00 am4:00 pm2023 Spotlight on SD Assisted Living Centers

04apr12:00 pm1:00 pmKeeping Your Cool When It Gets Heated: Diffusing Difficult InteractionsSDAHO Webinar

05apr10:00 am11:00 amHow You Help Save Lives: Organ, Eye and Tissue DonationSDAHO Webinar

06apr1:00 pm2:00 pmSDAHO's Post-Legislative Session Review (Members Only)SDAHO Webinar

06apr3:00 pm4:00 pmDay Drinking - Staying HydratedSDAHO Webinar

By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact